Advanced piperazine-containing inhibitors target microbial β-glucuronidases linked to gut toxicity. - Graboski AL; Simpson JB; Pellock SJ; Mehta N; Creekmore BC; Ariyarathna Y; Bhatt AP; Jariwala PB; Sekela JJ; Kowalewski ME; Barker NK; Mordant AL; et al. (RSC chemical biology, 2024)